Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vibrio cholerae O1 O-specific polysaccharide (OSP) is the primary surface antigen of the Vibrio cholerae bacterium, which causes the acute diarrheal disease cholera (Harris et al., 2012, https://pubmed.ncbi.nlm.nih.gov/22230232/). It is a component of the lipopolysaccharide (LPS) and determines the serogroup (O1) and serotypes such as Inaba and Ogawa (Chatterjee & Chaudhuri, 2003, https://pubmed.ncbi.nlm.nih.gov/12692281/). The OSP is composed of a homopolymer of alpha(1-2)-linked 4-amino-4,6-dideoxy-D-mannose (perosamine) residues (Villeneuve et al., 2000, https://pubmed.ncbi.nlm.nih.gov/10854134/). It is a critical target for the host immune system; antibodies against OSP, known as vibriocidal antibodies, are strongly correlated with protection against infection (Leung et al., 2004, https://pubmed.ncbi.nlm.nih.gov/15175298/). Therapeutically, OSP is the key component in oral cholera vaccines (OCVs) and is being developed as a conjugate vaccine (OSP-protein conjugates) to improve immunogenicity, especially in young children (Sarkar et al., 2019, https://pubmed.ncbi.nlm.nih.gov/31151943/). Targeting OSP via vaccination prevents the bacteria from colonizing the small intestine and neutralizes its pathogenic potential (World Health Organization, 2024, https://www.who.int/news-room/fact-sheets/detail/cholera).
Induction of protective vibriocidal antibodies and mucosal IgA to prevent bacterial colonization and promote pathogen neutralization.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vibrio cholerae O1 O-specific polysaccharide (OSP).